an overview of the monarch and neomonarch trials in breast cancer
Published 7 years ago • 48 plays • Length 2:20Download video MP4
Download video MP3
Similar videos
-
2:23
an overview of the neomonarch trial in hr /her2- breast cancer
-
1:13
overall survival data of the monarch-2 trial in hr /her2- breast cancer
-
0:50
next steps beyond the monarch 1 trial in breast cancer
-
1:13
significance of the monarch 2 findings for abemaciclib in hr /her2- breast cancer
-
8:39
final overall survival analysis of monarch 1
-
2:37
#esmo22 highlights on abemaciclib nsai in hr /her2- advanced breast cancer: the monarch 3 study
-
2:24
differentiating factors of abemaciclib among the cdk 4/6 inhibitors for breast cancer
-
1:33
ongoing trial of abemaciclib and pembrolizumab in hr /her2-negative breast cancer
-
0:49
breast cancer at esmo 2023: adcs and monarch 3
-
1:11
dr. rugo on the significance of the monarch i trial for breast cancer
-
8:55
cdk4/6 inhibitors in hr metastatic breast cancer
-
7:52
introduction and overview of her2-targeted therapies in breast cancer
-
5:32
esmo 2020 expert video report on cdk4 6i in the adjuvant treatment of breast cancer
-
1:12
monarche: adjuvant abemaciclib in hr breast cancer
-
0:52
exploring abemaciclib for the treatment of brain metastases in hr /her2- breast cancer
-
5:06
safety outcomes in the phase iii monarche trial of abemaciclib et in hr , her2- breast cancer
-
5:21
study of neratinib for patients with her2-positive breast cancer with brain metastases
-
2:31
results of the aphinity trial in her2-positive breast cancer
-
6:29
study of palbociclib after cdk & endocrine therapy in er /her2- metastatic breast cancer